REJIMUS
  • SERVICES
    • BUSINESS RESOURCES
    • FACILITY DESIGN
    • FACILITY REGISTRATION
    • LITIGATION CONSULTING
    • RECALLS
    • REGULATORY SUPPORT
    • OUTSOURCING QA
    • SPECIFICATIONS
  • COMPLIANCE
    • 21 CFR PART 101
    • 21 CFR PART 111
    • 21 CFR PART 117
    • 21 CFR PART 501
    • 21 CFR PART 701
    • CPG SEC. 400.400
  • LABEL REVIEWS
    • ELR & CLR
    • CLAIMS SUBSTANTIATION
    • CLAIMSBAE™ DATABASE
  • NDI & GRAS
    • NDI SERVICES
    • GRAS SERVICES
    • CO-DEVELOPMENT PARTNERSHIP
  • TRAINING
  • CASE STUDIES
  • CONTACT
  • ABOUT
    • JOBS
    • RESOURCES
    • NEWS AND MEDIA
      • NEWS
      • NEWSLETTERS
      • PODCASTS
      • PUBLICATIONS 2020
      • PUBLICATIONS 2019
      • PUBLICATIONS 2018
    • TEAM ARTICLES

Covid-19

Featured Image for covid-19 claims on dietary supplements

Dietary Supplements, Compliance, and COVID-19

Posted on by

Dietary Supplements, Compliance, and COVID-19 Tuesday, May 26, 2020Written by: Joel Villareal Dietary supplements and COVID-19? That is an interesting concept in the world today. With the current worldwide situation surrounding the pandemic, consumers alike are looking at various options to fight off a novel coronavirus, now named as COVID-19. It is a fact that[…]

Tagged Compliance, Covid-19, Dietary Supplement, FDA, Regulation

Posts navigation

RSS NutraIngredients

  • More trades react to sleepy FDA January 30, 2023
  • Study: Nitrate supplementation improves muscle performance January 30, 2023
  • Nutrasource rebrands clinical trial site to Apex Trials January 30, 2023

RSS WholeFoods

  • New Book by Sabinsa’s Dr. Muhammed Majeed Highlights Selenium Research  January 30, 2023
  • Cepham Monitors Triple-Dip La Niña to Plan for Supply Chain Disruptions January 27, 2023
  • Study: ThymoQuin with Astaxanthin Supports Gut-Immune-Brain Axis, Improves Mood    January 27, 2023

RSS NPI

  • Increased climate variability adding risks to botanical supply chain January 30, 2023
  • Health span > life span. Can we have both? January 30, 2023
  • Trade groups raise drug-spiked 'supplement' products in FDA meeting January 30, 2023
600 W. Santa Ana Blvd. Suite 1100 Santa Ana, CA 92701
info@rejimus.com
949 485 2112

REJIMUS™ 2022